Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC 228155 是一种 EGFR 的激活剂,与 sEGFR 二聚化结构域 II 结合并调节 EGFR 酪氨酸磷酸化。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 279 | 现货 | ||
5 mg | ¥ 397 | 现货 | ||
10 mg | ¥ 573 | 现货 | ||
25 mg | ¥ 1,180 | 现货 | ||
50 mg | ¥ 2,320 | 现货 | ||
100 mg | ¥ 3,480 | 现货 | ||
200 mg | ¥ 4,930 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 455 | 现货 |
产品描述 | NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation. |
靶点活性 | KIX-KID:0.36 μM |
体外活性 | NSC 228155 promotes transactivation of several RTKs, including ErbB2 and ErbB3, Insulin R and IGF-1 R receptors in the cells. It stimulates dimerization of sEGFR domain II[1]. NSC 228155 can rapidly move across cell membranes and disperse within both cytoplasmic and nuclear compartments. It rapidly generates hydrogen peroxide within cells[2]. NSC 228155 is also a potent inhibitor of KIX-KID interaction(IC50 = 0.36 μM), but it is not particularly selective against CREB-mediated gene transcription in HEK 293T cells[3]. |
细胞实验 | MDA MB468 cells serum-starved overnight are pre-incubated (or not) with 10?μM AG1478 or 2?μM PD 153035 for 90?min and then, where indicated, incubated with 100?μM NSC 228155 or CN 009543V or 150?ng/ml EGF or vehicle (0.2% DMSO) for 15?min. Proteins are blotted to nitrocellulose membrane and analyzed with biotinylated anti-pTyr P100, anti-pEGFR Y1068 and anti-EGFR (epitope in cytoplasmic region) antibodies. (Only for Reference) |
别名 | NSC228155 |
分子量 | 290.25 |
分子式 | C11H6N4O4S |
CAS No. | 113104-25-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 12 mg/mL (41.3 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.4453 mL | 17.2265 mL | 34.4531 mL | 86.1326 mL |
5 mM | 0.6891 mL | 3.4453 mL | 6.8906 mL | 17.2265 mL | |
10 mM | 0.3445 mL | 1.7227 mL | 3.4453 mL | 8.6133 mL | |
20 mM | 0.1723 mL | 0.8613 mL | 1.7227 mL | 4.3066 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NSC 228155 113104-25-9 Angiogenesis Cell Cycle/Checkpoint Chromatin/Epigenetic DNA Damage/DNA Repair JAK/STAT signaling Tyrosine Kinase/Adaptors Histone Acetyltransferase DNA/RNA Synthesis Epigenetic Reader Domain EGFR Epidermal growth factor receptor NSC-228155 HER1 HATs inhibit NSC228155 Inhibitor HAT ErbB-1 inhibitor